Shivom has recently announced a number of exciting partnerships, including those with the government in Andhra Pradesh to sequence up to 60 million people in that province of India, starting with a pilot study after the close of the token sale, as well as with publicly traded company Genetic Technologies Limited for development of predictive genetic tests and use of accredited laboratories.